EN
RU
Tirzepatide (CAS 2023788-19-2) is a GMP-compliant, high-purity dual GIP/GLP-1 receptor agonist peptide API. FDA-approved for type 2 diabetes glycemic control and chronic weight management, it delivers robust glucose-lowering and sustained weight loss efficacy. It fully meets ICH, USP and EP standards for injectable pharmaceutical R&D and commercial manufacturing.
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
2023788-19-2GlobalEquipX is a professional B2B cross-border platform dedicated to the global pharmaceutical, biotech and laboratory research sectors. Our core product portfolio covers pharmaceutical stability & environmental test chambers, laboratory centrifuges, automated lab glassware washers, water purification systems, vacuum & fluid processing equipment, evaporation & concentration systems, cleanroom environment monitoring instruments, plus matched pharmaceutical raw materials and biological enzyme preparations. We also provide supporting accessories, technical support and after-sales services to meet overseas clients' one-stop procurement needs.
5908-99-6 Atropine Sulfate
1542321-58-3 Benzgalantamine Gluconate
73963-72-1 Cilostazol
1285572-51-1 Dotinurad
1229194-11-9 Edoxaban
Tirzepatide (CAS 2023788-19-2) is a GMP-compliant, high-purity dual GIP/GLP-1 receptor agonist peptide API. FDA-approved for type 2 diabetes glycemic control and chronic weight management, it delivers robust glucose-lowering and sustained weight loss efficacy. It fully meets ICH, USP and EP standards for injectable pharmaceutical R&D and commercial manufacturing.
Public Account
IPv6 network supported
Product categories
Technical Articles
